Prostate cancer is the second cause of cancer related death in men. Historically, screening has consisted of serum PSA, digital rectal exams, and random US guided transrectal biopsy. Compared to older methods, mp-MRI is superior for the detection and staging of prostate cancer due to its improved visualization and lesion characterization. The PI-RADS classification system is a schema developed concordantly with mp-MRI in order to better characterize the clinical significance of imaging findings. Increasingly, mp-MRI is taking a central role in detection, staging and biopsy of prostate neoplasm. In the future it may emerge as a primary screening tool.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords